non glp-1 drugs for weight loss Popular medications may have health benefits that extend beyond and blood sugar control, a new study finds Chart: 1 in 8 Americans

A study involving treatment up to 104 or 117 weeks in 134 patients with T2DM showed EX microspheres-nave patients experienced weight reductions of -2.7 kg (116)

Forbes contributor Bruce Japsen reported in June 2026 that a growing share of health plans and employers are refusing to cover the drugs for weight loss, restricting coverage to diabetes indications or requiring prior authorisation hurdles that most patients cannot clear

The FDA is still looking into this issue

Liraglutide for perioperative management of hyperglycaemia in cardiac surgery patients: a multicentre randomized superiority trial

Your gut lining and your gut bacteria both play a role in GLP-1 secretion